LEADER 03400nam  2200721 a 450 
001 9910464696503321
005 20200520144314.0
010   $a1-283-62756-6
010   $a3-11-024614-7
010   $a9786613940018
024 7 $a10.1515/9783110246148
035   $a(CKB)3360000000446077
035   $a(EBL)893353
035   $a(OCoLC)1055362482$z(OCoLC)812253756
035   $a(SSID)ssj0000752423
035   $a(PQKBManifestationID)12308448
035   $a(PQKBTitleCode)TC0000752423
035   $a(PQKBWorkID)10786031
035   $a(PQKB)11393911
035   $a(MiAaPQ)EBC893353
035   $a(DE-B1597)57642
035   $a(OCoLC)820828214
035   $a(OCoLC)853255118
035   $a(DE-B1597)9783110246148
035   $a(Au-PeEL)EBL893353
035   $a(CaPaEBR)ebr10606551
035   $a(CaONFJC)MIL394001
035   $a(EXLCZ)993360000000446077
100   $a20101217d2012      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aIn vitro and in vivo hemolysis$b[electronic resource] $ean unresolved dispute in laboratory medicine /$fGiuseppe Lippi ... [et al.]
210   $aBerlin $cDe Gruyter$d2012
215   $a1 online resource (112 p.)
225 0 $aPatient Safety ;$v4
225  0$aPatient safety ;$vv. 4
300   $aDescription based upon print version of record.
311   $a3-11-214952-1 
311   $a3-11-024613-9 
320   $aIncludes bibliographical references and index.
327   $aDefinition of hemolysis -- Causes of hemolysis -- Prevalence of hemolytic specimens -- Interference of hemolysis on laboratory testing -- Detection of hemolytic specimens -- Management of hemolytic specimens.
330   $aDefined as red blood cell break down and the release of hemoglobin and intracellular contents into the plasma, hemolysis can seriously impact patient care as well as the laboratory's reputation through its affect on test results. Therefore, the European Preanalytical Scientific Committee, in collaboration with the International Federation of Clinical Chemistry Working Group on Patient Safety, have designed a questionnaire to collect data on prevalence and management of hemolytic specimens referred to the clinical laboratories for clinical chemistry testing. This book will help identify the areas where hemolysis occurs most frequently, which can, in turn, guide further analysis about why it is occurring. Once these elements are known, practices and procedures can be implemented to dramatically reduce hemolysis and avoid erroneous laboratory results affecting patient care and increasing laboratory costs.
410  0$aPatient Safety
606   $aHematology$xStandards
606   $aBlood$xExamination
608   $aElectronic books.
615  0$aHematology$xStandards.
615  0$aBlood$xExamination.
676   $a616.1/5
700   $aLippi$b Giuseppe$0736715
702   $aCervellin$b Gianfranco, $4aut$4http://id.loc.gov/vocabulary/relators/aut.
702   $aFavaloro$b Emmanuel J., $4aut$4http://id.loc.gov/vocabulary/relators/aut.
702   $aPlebani$b Mario, $4aut$4http://id.loc.gov/vocabulary/relators/aut.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910464696503321
996   $aIn vitro and in vivo hemolysis$92488858
997   $aUNINA